Daiichi Sankyo unveils APAC regional hub for RDPV QA operations in Singapore
Therapeutics | Company results | 1 Comment | 22 Feb, 2024
Daiichi Sankyo, an innovative global healthcare company, has launched its subsidiary Daiichi Sankyo Singapore ...Read more
Singapore approves AffaMed Therapeutics drug for Ocular Inflammation
Therapeutics | News | 0 Comment | 21 Feb, 2024
China's AffaMed Therapeutics, has obtained New Drug Application (NDA) from Singapore Health Sciences Authority (HSA...Read more
Australian govt injects $50 M to construct world-leading artificial heart
Therapeutics | News | 0 Comment | 20 Feb, 2024
The Australian government is providing $50 million to develop and commercialise the world’s most advanced artifici...Read more
Japan's Astellas Pharma inks oncology deal worth $800 M with US-based biotech startup Kelonia
Therapeutics | News | 0 Comment | 20 Feb, 2024
Japan headquartered Astellas Pharma and US-based biotech startup Kelonia Therapeutics have announced a collaborative eff...Read more
China develops potential new treatment for brain tumours and Parkinson’s disease
Therapeutics | News | 0 Comment | 15 Feb, 2024
A joint multi-disciplinary team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine...Read more
Latest insights on genetic testing related hearing loss
Therapeutics | Analysis | 0 Comment | 09 Feb, 2024
According to the World Health Organization (WHO), approximately 2.5 billion people worldwide are estimated to have some ...Read more
Korean startup C-Biomex announces oncology research partnership with US-based MD Anderson
Therapeutics | News | 0 Comment | 12 Feb, 2024
The University of Texas MD Anderson Cancer Center in the US, and South Korea-based startup C-Biomex have announced ...Read more
Australia's Recce partners Indonesia's Etana Biotech to advance anti-infective R&D, manufacturing
Therapeutics | News | 0 Comment | 08 Feb, 2024
Recce Pharmaceuticals Limited, the Company developing a New Class of Synthetic Anti-Infectives, has signed Memorand...Read more
Harnessing AI’s Potential for a Revolution in Cancer Screening
Therapeutics | Analysis | 1 Comment | 07 Feb, 2024
Imagine a world where a non-invasive breast cancer test delivers results within 15 minutes, costing less than half the p...Read more
Empowering Lives: Rare Disease Diagnostics and Awareness
Therapeutics | Analysis | 0 Comment | 07 Feb, 2024
Rare diseases, often overlooked, affect a significant portion of the global population. However, early detection and int...Read more
Sysmex and Hitachi High-Tech to collaboratively develop New Genetic Testing Systems
Therapeutics | News | 0 Comment | 08 Feb, 2024
Sysmex Corporation and Hitachi High-Tech Corporation are collaborating to develop novel genetic testing systems based on...Read more
AstraZeneca expands US manufacturing footprint to accelerate next-gen cell therapy development
Therapeutics | News | 0 Comment | 07 Feb, 2024
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell the...Read more
Australian government invests $20 M to find new therapies for childhood brain cancers
Therapeutics | News | 0 Comment | 05 Feb, 2024
The Australian government is funding a wide-ranging national research programme that will give new hope and help to Aust...Read more
Singapore develops new and precise way to treat most common type of brain cancer
Therapeutics | News | 0 Comment | 02 Feb, 2024
Researchers led by Nanyang Technological University, Singapore (NTU Singapore) have developed a new and precise way to t...Read more
Experts advocate HPV Vaccination Programmes for Gynaecologic Cancer prevention in MENA region
Therapeutics | Opinion | 0 Comment | 30 Jan, 2024
The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...Read more
Breakthroughs in Rare Diseases Therapeutics
Therapeutics | Analysis | By Anusha Ashwin | 1 Comment | 01 Feb, 2024
The previous year witnessed many promising developments in the fight against rare diseases. The recent Casgevy’s F...Read more
Trailblazing Impact of Antibody-Drug Conjugates
Therapeutics | Opinion | By Joe Daccache, Project Leader, DeciBio | 0 Comment | 01 Feb, 2024
The field of Antibody-Drug Conjugates (ADCs) has experienced a remarkable transformation, shifting from dormancy to a su...Read more
Next-Gen ADCs as Precision Weapon Against Cancer
Therapeutics | Analysis | By Ayesha Siddiqui | 1 Comment | 01 Feb, 2024
Cancer poses a significant challenge for the pharmaceutical industry, driving a constant search for improved oncology dr...Read more